Back to top

Analyst Blog

Luminex Corporation (LMNX - Analyst Report), a developer of biological testing technologies, has accomplished a major milestone with the shipment of its 10,000th multiplexing instrument. The company has shipped its 10,000th Magpix instrument to the Rhode Island Hospital, which will be used for assay validation of Luminex’s xTAG Gastrointestinal Pathogen Panel (GPP). 
 
The popularity and success of Luminex’s instruments demonstrate the company’s ability to develop world-class offerings. The open architecture and flexibility of the xMAP technology allows Luminex’s research partners to build assays as per their convenience.
 
Luminex’ revenues grew 9% in the last reported quarter, partially led by higher shipment of multiplexing analyzers, reflecting strong demand for Luminex products. The company shipped 205 multiplexing analyzers during the first quarter, resulting in total life-to-date dispatches of 9,865 analyzers, up 11% year over year.
 
Our Take
 
Luminex possesses an extensive product portfolio and a healthy pipeline of novel assays, which are expected to support growth going ahead. Moreover, Luminex is developing innovative platforms by combining resources from its latest acquisitions. The company’s initiative to establish a direct sales force for its molecular diagnostics customers will likely improve operating efficiency.
 
However, Luminex operates in a highly competitive life sciences industry. Sluggish growth in its core markets as well as the ongoing global austerity measures are challenges faced by the company. In addition, the loss of its assay distributors is affecting the bottom line.
 
The stock carries a Zacks Rank #3 (Hold). Medical instrument companies, such as Thoratec (THOR - Analyst Report), Globus Medical (GMED - Snapshot Report) and Syneron Medical (ELOS - Snapshot Report) are expected to do well. All these stocks carry a Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
SUPER MICRO… SMCI 27.00 +10.25%
CANADIAN SO… CSIQ 38.34 +8.18%
CENTURY ALU… CENX 26.97 +7.97%
WILLDAN GRO… WLDN 11.38 +5.86%
AROTECH COR… ARTX 3.78 +5.59%